Mpm Bioimpact LLC: holdings and changes

Number 25 of the top 100 funds by copy return. Mpm Bioimpact LLC reported 36 US stocks worth $1.3B for the quarter ending 2026-09-30 and changed 9 new, 7 added, 9 trimmed and 10 sold since 2026-06-30.

Copy return, 4 quarters+59.0%
US 500, same time+14.5%
Size$1.3B
Stocks36

Holdings

StockChangeWeightValueShares
CULLINAN ONCOL
Cullinan Oncology INC
11.49%$149M9,721,081
AKTS
Aktis Oncology INC
7.25%$94M4,835,872
TVTX
Travere Therapeutics INC
TRIM -3%4.93%$64M1,088,363
EWTX
Edgewise Therapeutics INC
4.93%$64M1,575,987
DYN
Dyne Therapeutics INC
ADD +67%3.98%$52M3,208,146
CORT
Corcept Therapeutics INC
TRIM -45%3.74%$49M422,000
RLAY
Relay Therapeutics INC
3.29%$43M2,369,578
TRVI
Trevi Therapeutics
TRIM -3%3.28%$43M2,978,906
IOVA
Iovance Biotherapeutics INC
BUY3.24%$42M2,835,734
LIQUIDIA TECHN
Liquidia Technologies INC
TRIM -3%3.13%$41M1,342,713
NTRA
Natera INC
2.88%$37M90,585
URGN
Urogen Pharma LTD
2.85%$37M909,691
IMCR
Immunocore Holdings Limited
BUY2.81%$36M1,203,289
DBVT
Dbv Technologies S A
TRIM -17%2.76%$36M3,044,659
TSHA
Taysha Gene Therapies INC Com Shs
ADD +61%2.72%$35M7,262,959
ABVX
Abivax Sa-Adr
2.50%$32M328,379
VIR
Vir Biotechnology INC
BUY2.42%$31M2,809,711
ANL
Adlai Nortye LTD
2.41%$31M1,956,618
VSTM
Verastem INC
BUY2.39%$31M3,851,604
QURE
Uniqure Nv
2.23%$29M1,201,413
ODTX
Odyssey Therapeutics, INC.
BUY2.20%$29M1,289,091
TARS
Tarsus Pharmaceuticals INC
ADD +10%2.13%$28M352,676
PVLA
Palvella Therapeutics INC Ne
TRIM -3%2.10%$27M197,633
ACRS
Aclaris Therapeutics INC
ADD +397%2.10%$27M5,178,127
ORKA
Oruka Therapeutics INC
BUY1.92%$25M300,000
ORIC
Oric Pharmaceuticals INC
TRIM -3%1.89%$24M1,821,951
STOK
Stoke Therapeutics INC
ADD +28%1.85%$24M925,133
BLTE
Belite Bio INC
1.74%$23M133,387
NGNE
Neurogene INC Com
BUY1.65%$22M771,839
ZURA
Zura Bio LTD
1.42%$18M4,449,671
ANNX
Annexon INC
ADD +21%1.40%$18M4,290,616
GLUE
Monte Rosa Therapeutics INC
TRIM -3%1.03%$13M1,125,216
BIOA
Bioage Labs INC
ADD +11%1.01%$13M1,856,748
CRBP
Corbus Pharmaceuticals Hldgs
BUY0.88%$11M1,667,272
DRUG
Bright Minds Biosciences INC
TRIM -3%0.75%$10M195,669
TRAX
First Tracks Biotherapeutics
BUY0.69%$9M254,374
RVMD
Revolution Medicines INC
SELL0%was $92M0
ALMS
Alumis INC
SELL0%was $57M0
RARE
Ultragenyx Pharmaceutical In
SELL0%was $47M0
DNTH
Dianthus Therapeutics INC
SELL0%was $41M0
MLTX
Moonlake Immunot
SELL0%was $31M0
SNDX
Syndax Pharmaceuticals INC
SELL0%was $29M0
FORTE BIOSCIEN
Forte Bioscience INC
SELL0%was $21M0
TRDA
Entrada Therapeutics, INC.
SELL0%was $9M0
CNTX
Context Therapeutics INC
SELL0%was $700k0
HOWL
Werewolf Therapeutics INC
SELL0%was $0k0

Copy return each quarter

HeldFund copyUS 500
2023-03-31 → 2023-06-30+13.3%+8.3%
2023-12-31 → 2024-03-31+20.2%+10.0%
2024-03-31 → 2024-06-30-5.6%+4.0%
2024-06-30 → 2024-09-30+2.5%+5.4%
2024-09-30 → 2024-12-31-11.5%+2.1%
2024-12-31 → 2025-03-31-19.7%-4.6%
2025-03-31 → 2025-06-30+1.6%+10.5%
2025-06-30 → 2025-09-30+19.4%+7.8%
2025-09-30 → 2025-12-31+39.0%+2.4%
2025-12-31 → 2026-03-31+6.7%-4.6%
2026-03-31 → 2026-06-30+32.2%+14.8%
2026-06-30 → 2026-09-30-18.8%+2.1%

The copy return buys the fund's reported stocks on the day after the filing became public and holds them for one quarter, so it measures what anyone reading the filings could have done.

All top 100 funds, live

Other top funds

Nextech Invest LTD.Venrock Adviser, LLCFairmount Funds Management LLCTalos Eurisko Asset Management LPAnalog Century Management LPQvt Financial LPBroad Peak Investment Advisers Pte LTDWs Management LllpBvf INC/IlParadigm Biocapital Advisors LPOak Grove Capital LLCCm Wealth Advisors LLCAvidity Partners Management LPFirst Light Asset Management, LLCLogos Global Management LPSummit Street Capital Management, LLCMadison Avenue Partners, LPDivisar Capital Management LLCTcg Crossover Management, LLCOptimus Prime Fund Management Co., LTD.Value Aligned Research Advisors, LLCBraidwell LPRedmile Group, LLCOrbimed Advisors LLCCloudalpha Capital Management Limited/Hong KongGeneral Pension Society Pzu Joint Stock CoAmanah Holdings TrustSlate Path Capital LPDeep Track Capital, LP